Regeneron Pharmaceuticals, Inc. (REGN)
692.58
-10.68
(-1.52%)
USD |
NASDAQ |
Dec 09, 16:00
692.58
0.00 (0.00%)
After-Hours: 07:17
Regeneron Pharmaceuticals Market Cap: 72.79B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 169.00B |
| Johnson & Johnson | 481.76B |
| Eli Lilly & Co. | 879.11B |
| Merck & Co., Inc. | 240.48B |
| Pfizer Inc. | 144.02B |
Market Cap Related Metrics
| PE Ratio | 16.58 |
| PS Ratio | 5.357 |
| PEG Ratio | 4.931 |
| Price to Book Value | 2.351 |
| Price to Free Cash Flow | 19.67 |
| Price | 692.58 |
| Earnings Yield | 6.03% |
| PEGY Ratio | 4.931 |
| Operating PE Ratio | 19.93 |
| Normalized PE Ratio | 17.26 |